Estrogen and Progesterone Receptor Analyses in More Than 4000 Human Breast Cancer Samples: A Study with Special Reference to Age at diagnosis and stability of analyses

References

• McGuire W. L., Osborne C. K., Clark G. M., Knight W. A. Steroid hormone receptors and carcinoma of the breast. Am J Phy-siol 1982; 243: 99–102
   Google Scholar
• McGuire W. L., Clark G. M., Dressler L. G., Owens M. A. Role of steroid hormone receptors as prognostic factors in primary breast cancer. NCI Monographs 1986; 1: 19–23
   Google Scholar
• Rose C., Thorpe S. M., Andersen K. W., et al. Beneficial effect of adjuvant tamoxifen therapy in primary breast cancer patients with high oestrogen receptor values. Lancet 1985; 1: 16–9
   PubMed Web of Science ®Google Scholar
• Stewart H. J., Prescott R. Adjuvant tamoxifen therapy and receptor levels. Lancet 1985; 1: 573
   PubMed Web of Science ®Google Scholar
• Baum M., Brinkley D. M., Dossett J. A., et al. Controlled trial of tamoxifen as single adjuvant agent in management of early breast cancer. Lancet 1985; 1: 836–40
   PubMed Web of Science ®Google Scholar
• Howat J. M. T., Barnes D. M., Harris M., Swindell R. The association of cytosol oestrogen and progesterone receptors with histological features of breast cancer and early recurrence of disease. Br J Cancer 1983; 47: 629–40
   PubMed Web of Science ®Google Scholar
• Shapiro C. M., Schifeling D., Bitran J. D., et al. Prognostic value of the estrogen receptor level in pathologic stage I and II adenocarcinoma of the breast. J Surg Oncol 1982; 19: 119–21
   PubMed Web of Science ®Google Scholar
• Villadsen S., Jeune B., Kongshavn T., Pedersen Hoy S. The age of the menopause. Methodological problems in historic, and geographic comparisons. Ugeskr Laeger 1985; 147: 3637–41
   PubMedGoogle Scholar
• Norgren A., Borg Å., Fernöo M., Johansson U., Lindahl B. Tsiobanelis K. Improved method for assay of estradiol and progesterone receptors with special reference to breast cancer. Anticancer Res 1982; 2: 315–20
   PubMed Web of Science ®Google Scholar
• Fernö M. Thesis. Malmö. Infotryck AB, Sweden 1985
   Google Scholar
• DeSombre E. R., Carbone P. P., Jensen E. V., et al. Steroid receptors in breast cancer. N Eng J Med 1979; 301: 1011–2
   PubMed Web of Science ®Google Scholar
• Fernö M., Borg Å., Norgren A. A comparison of two steroid receptor assays in breast cancer: dextran coated charcoal and isoelectric focusing. Anticancer Res 1983; 3: 243–6
   PubMed Web of Science ®Google Scholar
• Fernö M., Borg Å., Sellberg G. Enzyme immunoassay of the estrogen receptor in breast cancer biopsy samples. A comparison with isoelectric focusing. Acta Radiol Oncol 1986; 25: 171–5
   PubMed Web of Science ®Google Scholar
• Fernö M., Borg Å., Johansson U. Enzyme immunoassay of progesterone receptor in breast cancer biopsy samples. A comparison with the dextran coated charcoal method. Acta Oncol 1989; 28: 19–22
   PubMed Web of Science ®Google Scholar
• Lowry O. H., Roseborough N., Farr L., Randall R. J. Protein measurement with the Fohn phenol reagent. J Biol Chem 1951; 193: 265–75
   PubMed Web of Science ®Google Scholar
• Burton K. A study of the conditions and mechanism of the diphenylamine reaction for the colorimetric estimation of deoxyribonucleic acid. Biochem J 1956; 62: 315–23
   PubMed Web of Science ®Google Scholar
• EORTC Breast Cooperative Group. Revision of the standards for the assessment of hormone receptors in human breast cancer: Report of the Second EORTC Workshop, Held on 16–17 March, 1979, in the Netherlands Cancer Institute. Eur J Cancer 1980; 16: 1513–5
   PubMed Web of Science ®Google Scholar
• Norgren A., Fernö M., Borg Å. Observations on wet weight protein and DNA as reference for steroid receptors in malignant mammary tumours. Anticancer Res 1986; 6: 59–64
   PubMed Web of Science ®Google Scholar
• Thorpe S. M. Estrogen and progesterone receptor determinations in breast cancer. Technology, biology and clinical significance. Acta Oncol. 1988; 27: 1–19
   PubMed Web of Science ®Google Scholar
• Williams R. H. Textbook of Endocrinology. Saunders WB Co, Washington 1981; 60
   Google Scholar
• Heise E., Görlich M. Estradiol receptor in human breast cancers throughout the menstrual cycle. Oncology 1982; 39: 340–4
   PubMed Web of Science ®Google Scholar
• Saez S., Chouvet C. Influence of endogenous hormone levels on tumor estradiol and progesterone receptors. Recent Results Cancer Res 1984; 91: 150–6
   PubMedGoogle Scholar
• Weimer D. A., Weimer W. L. Changes in estrogen and progesterone receptor content of primary breast carcinoma during the menstrual cycle. Breast Cancer Res Treat 1987; 10: 273–8
   PubMed Web of Science ®Google Scholar
• Olsson H. Reproductive events, occurring in adolescence at the time of development of reproductive organs and at the time of tumour initiation, have a bearing on growth characteristics and reproductive hormone regulation in normal and tumour tissue investigated decades later—a hypothesis. Med Hypotheses 1989; 28: 93–7
   PubMed Web of Science ®Google Scholar
• Thorpe S. M. Immunological quantitation of nuclear receptors in human breast cancer. Relation to cytosolic estrogen and progesterone receptors. Cancer Res 1987; 47: 1830–5
   PubMed Web of Science ®Google Scholar
• Norgren A., Forsberg A. H., Lindgren A., Ilström Sä J. Menopausal status and cut-off levels in steroid receptor ligand binding assays in breast cancer. Anticancer Res 1989; 9: 173–6
   PubMed Web of Science ®Google Scholar
• Holdaway I. M., Mason B. H., Kay R. G. Steroid hormone receptors in breast turnours presenting during pregnancy or lactation. J Suig Oncol 1984; 25: 38–41
   PubMed Web of Science ®Google Scholar
• Janssens J. P. H., Bonte J., Drochmans A., et al. Effect of presur-gical radiotherapy on the steroid receptor concentrations in primary breast carcinoma. Eur J Cancer 1981; 17: 659–64
   Web of Science ®Google Scholar
• Olsson H., Borg Å., Ewers S. B., Fernö M., Möller T., Ranstam J. A biological marker, strongly associated with early oral contraceptive use, for the selection of a high risk group for premenopausal breast cancer. Med Oncol Tumor Pharma-cother 1986; 3: 77–81
   PubMedGoogle Scholar
• Hulka B. S., Chambless L. E., Wilkinson W. E., et al. Hormonal and personal effects on estrogen receptors in breast cancer. Am J Epidemiol 1984; 119: 692–704
   PubMed Web of Science ®Google Scholar
• Lesser M. L., Rosen P. P., Senie R. T., et al. Estrogen and progesterone receptors in breast carcinoma: correlations with epidemiology and pathology. Cancer 1981; 48: 299–309
   PubMed Web of Science ®Google Scholar
• Osborne M. P., Rosen P. P., Lesser M. L., et al. The relationship between family history, exposure to exogenous hormones. and estrogen receptor protein in breast cancer. Cancer 1983; 51: 2134–8
   PubMed Web of Science ®Google Scholar
• Stanford J. L., Szklo M., Boring C. C., et al. A case-control study of breast cancer stratified by estrogen receptor status. Am J Epidemiol 1987; 125: 184–94
   PubMed Web of Science ®Google Scholar
• Thomas D. Hormones and hormone receptors in the etiology of breast cancer. Breast Cancer Res Treat 1986; 7: 11–22, (Suppl)
   Web of Science ®Google Scholar